Exerkine Company
Exerkine Corporation is a biotech-pharmaceutical company that is developing highly effective new therapies to treat a variety of genetic.
Industry:
Geroscience
Technology:
Geroscience
Estimated Revenue:
$1M to $10M
Headquarters:
Canada
Investor Type:
For Profit